Sanders Capital, LLC — 13F Portfolio

Sanders Capital, LLC operates as a concentrated, research-intensive investment management firm based in New York, filing with the SEC under CIK #0001508097. Founded in 2007 by Lewis A. Sanders following his distinguished tenure as Chairman and CEO of AllianceBernstein, the firm was established on the principle of managing institutional capital through high-conviction, quality-focused equity strategies with patient holding periods. Sanders Capital serves a selective client base of sophisticated institutional investors including corporate and public pension funds, endowments, foundations, and sovereign wealth entities seeking differentiated active management with concentrated positioning and long-term orientation. The firm's 13F filings reflect a focused portfolio of typically 20-30 holdings representing the investment team's highest-conviction ideas identified through intensive fundamental research and business quality assessment. The organizational structure emphasizes partnership culture, analytical depth, and alignment with client objectives through concentrated mandates that differ markedly from diversified traditional asset managers. Lewis Sanders brought decades of institutional investment experience and a distinctive investment philosophy centered on identifying exceptional businesses with sustainable competitive advantages, strong management teams, and attractive long-term growth prospects trading at reasonable valuations relative to quality and growth characteristics. This Growth at Reasonable Price (GARP) orientation distinguishes Sanders Capital from pure growth managers willing to pay any price for momentum and pure value investors focused primarily on statistical cheapness regardless of business quality. The firm's selective client acceptance, high minimum account sizes, and concentrated strategy implementation create an institutional boutique profile appealing to sophisticated allocators seeking differentiated exposure and willing to accept tracking error and concentration risk inherent in conviction-weighted portfolios. Sanders Capital's investment approach reflects founder philosophy and team continuity, with key portfolio managers including Michael Lauer, George Gwynn, and Rahul Naik bringing extensive experience and specialized sector expertise to collaborative investment decisions. The firm maintains low portfolio turnover reflecting patient capital orientation and willingness to hold quality businesses across market cycles, accepting interim volatility when fundamental business strength remains intact. This long-term holding period approach reduces transaction costs, enhances tax efficiency, and allows compounding to work across extended time horizons when business fundamentals and competitive positioning strengthen. The 13F History available through regulatory filings provides transparency into how this concentrated, quality-focused strategy has positioned capital across technology disruption, sector rotation, valuation regime shifts, and multiple market cycles since the firm's 2007 founding.

Sanders Capital employs a fundamental research-driven investment philosophy emphasizing business quality, competitive advantage sustainability, management excellence, and attractive risk-adjusted return potential at reasonable valuations. The strategy seeks to identify franchise businesses with durable competitive moats including network effects, high switching costs, brand strength, regulatory barriers, or technological leadership that enable sustained pricing power and market share gains. Portfolio managers conduct exhaustive due diligence including extensive management meetings, competitive analysis, customer and supplier interviews, industry expert consultations, and detailed financial modeling to develop conviction in business durability and long-term value creation potential. This research intensity supports concentrated portfolio construction, with the 13F Portfolio Composition typically revealing 20-30 core holdings rather than the 50-100+ positions common among diversified institutional managers. The investment process integrates quantitative screening to identify potential candidates meeting quality and valuation criteria with deep qualitative assessment of competitive dynamics, management capability, corporate governance, and strategic positioning. The firm evaluates return on invested capital, free cash flow generation, balance sheet strength, and earnings quality as quantitative indicators of business franchise strength, while qualitative analysis assesses innovation capability, customer loyalty, employee culture, and strategic vision. Valuation discipline prevents overpaying for quality, with the team seeking situations where market participants underappreciate business strength, growth durability, or competitive advantage widening, creating opportunity to acquire exceptional franchises at reasonable multiples relative to long-term earnings power and cash flow generation. Sector allocation emerges from bottom-up security selection rather than top-down thematic mandates, though the quality growth orientation naturally gravitates toward sectors offering abundant opportunities for sustainable competitive advantage and secular growth. Technology exposure reflects identification of platform businesses, mission-critical software providers, and digital infrastructure companies with network effects and recurring revenue models. Healthcare holdings span biopharmaceutical innovators with strong drug pipelines, medical device leaders with technological differentiation, and healthcare services businesses benefiting from aging demographics and utilization trends. Financial services positions emphasize business model evolution, digital transformation, and competitive positioning within consolidating industries. The Sector Allocation History reveals meaningful sector concentration compared to broad market indices, reflecting conviction in identified opportunities rather than benchmark-aware diversification. Position sizing directly correlates with conviction levels, investment team agreement, and risk assessment, with largest holdings representing businesses exhibiting strongest combination of quality, growth, and valuation characteristics. The firm maintains patience in holding periods, with core positions held across years as business fundamentals compound and competitive advantages strengthen. This low-turnover approach contrasts sharply with momentum strategies or tactical traders, accepting that quarterly or even annual performance may diverge significantly from benchmarks when market leadership rotates away from quality growth. Portfolio construction accepts concentration risk as inherent to high-conviction investing, with the team maintaining that superior risk-adjusted returns emerge from concentrated exposure to best ideas rather than broad diversification diluting alpha through inclusion of lower-conviction positions.

Sanders Capital, LLC represents a distinctive institutional boutique employing concentrated, research-intensive investment management focused on quality growth businesses acquired at reasonable valuations. The firm's 13F filings document implementation of a high-conviction strategy that concentrates capital in 20-30 exceptional franchises identified through exhaustive fundamental analysis, accepting tracking error and concentration risk in pursuit of differentiated long-term returns. Examining the Historical Track Record since the firm's 2007 founding reveals performance patterns characteristic of concentrated quality growth investing—extended periods of outperformance during quality business leadership punctuated by corrections during value rotations and growth multiple compression. The Annualized Return (CAGR) achieved across full cycles demonstrates the compounding power of owning exceptional businesses held patiently through volatility, though measurement period selection critically affects perceived results given the strategy's regime-dependent characteristics. The Sharpe Ratio and risk-adjusted metrics associated with Sanders Capital's approach reflect tension between concentration-driven volatility and long-term alpha generation through superior security selection. For sophisticated institutional allocators evaluating the firm's capabilities, disclosed positioning provides transparency into portfolio construction and highest-conviction views, with quarterly 13F snapshots revealing relatively stable core holdings given the low-turnover investment approach. The focused mandate and patient holding periods mean position changes carry particular significance, with new additions representing identified opportunities meeting rigorous quality and valuation criteria while exits signal material changes in fundamental outlook or valuation reassessment. Portfolio backtesting through disclosed filings enables examination of how the strategy navigated post-financial crisis recovery, technology platform dominance, late-cycle growth leadership, pandemic disruption, and recent inflation-driven correction—each period testing different aspects of business quality assessment and valuation discipline. Critical analytical questions include: How has position concentration evolved since inception, and what does this reveal about conviction levels, opportunity set changes, or risk tolerance adaptation? Which core holdings have anchored the portfolio across extended periods, and what common characteristics distinguish these multi-year positions from shorter-duration investments? How does Sanders Capital's GARP framework balance quality assessment with valuation discipline, and where does the approach differ from pure growth managers or traditional value investors? To what extent has the definition of sustainable competitive advantage evolved amid digital disruption, platform economics, and intangible asset dominance, requiring updated frameworks for evaluating modern business models versus traditional industrial franchises? How would concentrated quality growth positioning perform under alternative interest rate scenarios, competitive disruption patterns, or regulatory interventions affecting technology platform economics and healthcare innovation incentives? Understanding the regime-dependency of concentrated quality growth strategies—and the institutional patience required to harvest compounding benefits across full market cycles rather than optimizing for short measurement periods—remains essential for appropriate strategy allocation within diversified portfolios and realistic expectations regarding interim volatility and tracking error inherent in differentiated, conviction-weighted institutional mandates.

Sanders Capital's risk characteristics reflect its concentrated, quality-growth investment approach which introduces substantial active risk relative to broad market benchmarks. The firm's typical portfolio of 20-30 holdings creates significant idiosyncratic risk, where individual company disappointments—competitive disruption, management missteps, regulatory challenges, or secular headwinds—can materially impact overall portfolio performance given outsized position weights. Top 10 Holdings Concentration routinely exceeds 50-60% of portfolio value, meaningfully above the 20-30% typical of diversified institutional managers, creating amplified sensitivity to individual security outcomes. This concentration strategy presumes that intensive fundamental research and business quality focus will identify durable winners whose long-term compounding overwhelms inevitable individual position failures, requiring patient capital and tolerance for interim volatility. The Volatility Profile associated with Sanders Capital's approach exhibits characteristics typical of concentrated growth-oriented portfolios, with above-market volatility during corrections affecting large-cap technology and quality growth stocks. The GARP orientation provides some valuation discipline versus pure momentum growth strategies paying any price, potentially offering downside protection when expensive growth names experience multiple compression. However, the concentration and growth tilt ensure meaningful participation in corrections affecting portfolio holdings, with diversification benefits limited by the focused mandate. The 2018 fourth quarter selloff, 2020 pandemic volatility, and 2022 growth stock bear market each tested different aspects of the portfolio, with technology concentration and quality premium valuations facing headwinds during risk-off episodes and rising rate environments compressing long-duration earnings multiples. The Max Drawdown Depth during severe market corrections can approach or exceed market indices given concentration risk and growth stock beta, though the quality focus and balance sheet strength of holdings may provide relative resilience during fundamental recessions when lower-quality businesses face existential threats. The 2008-2009 financial crisis occurred before Sanders Capital's founding, though Lewis Sanders' prior experience managing institutional portfolios through that period informed the firm's risk management philosophy and business quality emphasis. Recovery trajectories following drawdowns depend on whether portfolio holdings maintain competitive positioning and emerge from volatility with strengthened market positions, with quality businesses historically demonstrating faster earnings recovery than lower-quality cyclicals facing impaired balance sheets and competitive pressures. Sanders Capital manages risk primarily through fundamental research quality and business selection rather than quantitative diversification or hedging overlays, maintaining conviction that intensive analysis identifying truly exceptional franchises provides superior risk management compared to statistical portfolio construction. The firm monitors position concentration, sector exposures, and correlation patterns while allowing bottom-up conviction to drive allocation decisions. The Downside Capture Ratio varies across correction types—broad market selloffs see elevated downside capture due to concentration and growth characteristics, while sector-specific or idiosyncratic events may demonstrate resilience if portfolio holdings avoid direct exposure. Liquidity management benefits from positions concentrated in mega-cap and large-cap names with deep trading volumes, though institutional position sizes mean execution during volatility requires careful management to avoid market impact.